At Johnson & Johnson, we take on the most pervasive diseases that burden hundreds of millions of people and healthcare systems around the world. As part of this long-standing commitment and propelled by our successes in treating thrombosis, we advance highly differentiated therapies that prevent and treat life-threatening cardiovascular diseases. The prevalence of these diseases is growing, straining patients, their families and healthcare systems. Uncovering new therapies that have the potential to improve the lives of this large segment of the population is an important endeavor—one which we will continue to lead in the years to come. Our relentless pursuit of innovation means patients get the treatments they need as fast as possible.